,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2013-06-27 22:20:00,"In a bid to expand its international operation, St. Jude Medical ( STJ ) has launched its Accent MRI Pacemaker and the Tendril MRI lead in Japan.",0.9057638645172119,0.012530936859548092,0.08170510828495026,positive,0.8932329416275024
1,2013-06-27 22:20:00,"This follows an approval from the Japanese Ministry of Health, Labor and Welfare (MHLW).",0.4773351848125458,0.010531805455684662,0.512133002281189,neutral,0.4668033719062805
2,2013-06-27 22:20:00,This also remains in line with the company's plan to launch the pacemaker in the Japanese market by mid-2013.,0.8375963568687439,0.012308011762797832,0.15009567141532898,positive,0.8252883553504944
3,2013-06-27 22:20:00,"Patients with traditional pacing systems cannot receive MRI scans, as the device might get damaged.",0.026915596798062325,0.793789803981781,0.17929460108280182,negative,-0.7668741941452026
4,2013-06-27 22:20:00,The uniqueness of the Accent MRI pacemaker lies in the fact that it is capable of delivering full-body magnetic resonance imaging (MRI) scans using high-power imaging technology.,0.2882782816886902,0.007088921964168549,0.7046327590942383,neutral,0.28118935227394104
5,2013-06-27 22:20:00,"The Tendril lead platform, featuring the Optim lead insulation, enhances the flexibility and safety of the device.",0.8150097131729126,0.01163346879184246,0.17335687577724457,positive,0.8033762574195862
6,2013-06-27 22:20:00,Two different models of the pacemaker are commercially available viz.,0.019781995564699173,0.010880161076784134,0.9693378210067749,neutral,0.008901834487915039
7,2013-06-27 22:20:00,"the Accent MRI DR and the Accent MRI SR.

Cardiac devices are used to provide electrical stimulation to the heart when it beats slowly.",0.02118510939180851,0.00970168225467205,0.9691131711006165,neutral,0.01148342713713646
8,2013-06-27 22:20:00,"According to The New England Journal of Medicine, about 1.25 million people in the world are implanted with a pacemaker every year.",0.12615634500980377,0.04775625839829445,0.8260874152183533,neutral,0.07840009033679962
9,2013-06-27 22:20:00,"St. Jude, a large player in the Cardiac Rhythm Management (CRM) market, should be able to capture significant market share with its new technologies.",0.9367252588272095,0.01357352640479803,0.049701228737831116,positive,0.9231517314910889
10,2013-06-27 22:20:00,"However, St. Jude's core CRM division is still underperforming as the underlying market remains weak.",0.022607048973441124,0.9569782018661499,0.020414700731635094,negative,-0.9343711733818054
11,2013-06-27 22:20:00,The pacemaker business under the company's CRM division is losing market share due to competitive pressure and volume/pricing headwinds in international markets.,0.017804471775889397,0.9687743186950684,0.013421211391687393,negative,-0.9509698748588562
12,2013-06-27 22:20:00,Pacemaker sales plunged 11% in constant currency to $251 million in the last reported quarter.,0.01713128201663494,0.9735279679298401,0.009340770542621613,negative,-0.9563966989517212
13,2013-06-27 22:20:00,"Additionally, pricing pressure in Japan is on the rise.",0.8612884879112244,0.08578705042600632,0.052924398332834244,positive,0.7755014300346375
14,2013-06-27 22:20:00,The CE Marked Accent MRI pacemaker is experiencing strong adoption and premium pricing in the markets in which it has already been launched.,0.9384701251983643,0.014392124488949776,0.0471377857029438,positive,0.9240779876708984
15,2013-06-27 22:20:00,The Japanese launch of this product should help STJ's soft pacemaker business regain market share.,0.9511786103248596,0.018108876422047615,0.030712563544511795,positive,0.9330697059631348
16,2013-06-27 22:20:00,We believe that the sluggish pacemaker business is likely to pick up pace toward the end of 2013 with new product launches in Europe and Japan.,0.8491399884223938,0.013466857373714447,0.13739319145679474,positive,0.8356731534004211
17,2013-06-27 22:20:00,The company plans to launch 5 new pacemakers in Europe and Japan in 2013.,0.4529435336589813,0.008938225917518139,0.5381182432174683,neutral,0.4440053105354309
18,2013-06-27 22:20:00,"Recently, the company received CE Mark approval for its Allure Quadra Cardiac Resynchronization Therapy Pacemaker (CRT-P).",0.8708166480064392,0.01264719944447279,0.11653611809015274,positive,0.858169436454773
19,2013-06-27 22:20:00,It is the world's first pacemaker with the quadripolar lead technology.,0.46456223726272583,0.01003660075366497,0.5254011750221252,neutral,0.4545256495475769
20,2013-06-27 22:20:00,St. Jude currently carries a Zacks Rank #3 (Hold).,0.03989259898662567,0.020126808434724808,0.9399806261062622,neutral,0.019765790551900864
21,2013-06-27 22:20:00,"While we remain on the sidelines regarding STJ, Haemonetics ( HAE ), Edwards Lifesciences ( EW ) and Resmed ( RMD ) are worth considering.",0.07566636055707932,0.005460876505821943,0.9188727736473083,neutral,0.07020548731088638
22,2013-06-27 22:20:00,"HAE carries a Zacks Rank #1 (Strong Buy), while the other two stocks carry a Zacks Rank #2 (Buy).",0.2801920473575592,0.021434925496578217,0.698373019695282,neutral,0.2587571144104004
23,2013-06-27 22:20:00,To read this article on Zacks.com click here.,0.017961200326681137,0.01924508437514305,0.9627937078475952,neutral,-0.001283884048461914
24,2013-06-27 22:20:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204561054706573,0.01563790813088417,0.9741575717926025,neutral,-0.005433347076177597
